News | September 24, 2014
September 24, 2014 — A new study that compares the use of an everolimus-eluting...
ABSORB II Study DES Xience Abbot Vascular
Feature | September 24, 2014
September 24, 2014 — Abbott announced positive one-year clinical results from ABSORB II, the world's first prospective...
Capricor ALLSTAR Phase I Clinical Trial TCT 2014 Stem Cells Myocardial Regenerat
News | September 24, 2014
September 24, 2014 — Capricor Therapeutics Inc. presented an abstract entitled "ALLogeneic Heart STem Cells To Achieve...
Technology | September 24, 2014
September 24, 2014 — GE Healthcare announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Discovery...
News | September 23, 2014
September 23, 2014 — New analyses and extended follow-up from the BRIGHT...
Two-Year Results CoreValve U.S. Pivotal Trial TCT 2014
News | September 23, 2014
September 23, 2014 — In extended follow-up from the CoreValve U.S. Pivotal Trial, the self-expanding transcatheter...
Feature | September 22, 2014
September 22, 2014 — A first-of-its kind study found that using a cerebral protection device during...
News | September 22, 2014
September 22, 2014 — According to a new study, while it is common for patients who have migraine to have a patent...
VADs Gain Popularity Artificial Hearts Remain Ideal GlobalData
Feature | September 22, 2014
September 22, 2014 — Robert Littlefield, MSc, GlobalData's senior analyst covering Medical Devices, said: “Since the...
U.S. CoreValve High Risk trial TCT 2014
Feature | September 19, 2014
September 19, 2014 — According to a new study,...
Study Blood Thinner Heart Attack Patients
Feature | September 19, 2014
September 19, 2014 — The largest prospective longitudinal...
Feature | September 19, 2014
September 19, 2014 — A new study investigating different durations of triple therapy for anticoagulation after...
Feature | September 19, 2014
September 19, 2014 — According to a new study,...
PARTNER I Trial TCT 2014 TAVR Heart Valve Repair
News | September 18, 2014
September 18, 2014 — New data from a landmark clinical trial found that after five years, t...
Overlay Init